{
    "title": "Impax Labs on the hunt after striking two deals worth $700 mln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2786906/Impax-Labs-hunt-striking-two-deals-worth-700-mln.html",
    "date": "2014-10-09",
    "keywords": [
        "drug",
        "percent",
        "tax",
        "inversion",
        "tower",
        "company",
        "food",
        "hunt",
        "october",
        "acquisition",
        "pennsylvania",
        "trading",
        "lineage",
        "impax",
        "deal",
        "revenue",
        "labs",
        "mln",
        "gmt",
        "email",
        "oct",
        "transaction",
        "morning",
        "nasdaq",
        "inc",
        "access",
        "emergency",
        "antiallergen",
        "injection",
        "executive",
        "frederick",
        "wilkinson",
        "hayward",
        "dealsif",
        "benefit",
        "conference",
        "call",
        "base",
        "taxeshowever",
        "treasury",
        "department",
        "way",
        "worm",
        "marketlineage",
        "betepinephrine",
        "windpipe",
        "latexfour",
        "allergy",
        "disease",
        "control",
        "preventionlineage",
        "autoinjector",
        "system",
        "version",
        "drugboth",
        "mylan",
        "leader",
        "markettower",
        "sale",
        "productsthe",
        "share",
        "administration",
        "companys",
        "factory",
        "taiwan",
        "fda",
        "california",
        "plantthe",
        "fdas",
        "scrutiny",
        "doubt",
        "future",
        "impaxs",
        "afternoon",
        "stock",
        "year",
        "reporting",
        "vidya",
        "l",
        "nathan",
        "rao",
        "koppala",
        "bangalore",
        "editing",
        "kerr",
        "savio",
        "dsouza"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}